Effects of Transcutaneous Tibial Nerve Stimulation in Women Refractory to and Never Used Pharmacological Agents for Idiopathic Overactive Bladder

被引:0
作者
Yildiz, Necmettin [1 ]
Celtek, Merve Arbay [1 ]
机构
[1] Pamukkale Univ, Dept Phys Med & Rehabil, Fac Med, TR-20160 Denizli, Turkiye
关键词
Anti-muscarinics; ss3 adrenoreceptor agonist; Idiopathic overactive bladder; Transcutaneous tibial nerve stimulation; INTRAVAGINAL ELECTRICAL-STIMULATION; URINARY-INCONTINENCE; EFFICACY; MANAGEMENT; IMPACT; TRIAL; OAB;
D O I
10.1007/s00192-023-05704-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction and hypothesis The aim of this study is to compare the effectiveness of transcutaneous tibial nerve stimulation (TTNS) on quality of life (QoL) and clinical parameters related to incontinence in pharmacological agents (PhAs) naive and refractory women with idiopathic overactive bladder (iOAB).Methods In this prospective nonrandomized clinical trial, women with resistance to PhAs were included in the first group (n=21), PhA-naive women were included in the second group (n=21). TTNS was performed 2 days a week, a total of 12 sessions for 6 weeks. Every session lasted 30 min. Women were evaluated for the severity of incontinence (Pad test), 3-day voiding diary (voiding frequency, nocturia, incontinence episodes, and number of pads), symptom severity (Overactive Bladder Questionnaire-V8), quality of life (Incontinence Impact Questionnaire-7), treatment satisfaction, positive response, and cure-improvement rates.Results A statistically significant improvement was found in all parameters for each group at the 6th week compared with the baseline values (p<0.05). It was found that the severity of incontinence, incontinence episodes, symptom severity, treatment satisfaction, and QoL parameters were significantly improved in PhA-naive group compared with the PhA-resistant group at the 6th week (p<0.05). There were no statistically significant differences in the frequency of voiding, nocturia, and number of pads between the two groups (p>0.05). Positive response rates, the primary outcome measure, were statistically significantly higher in the PhA-naive group than in the PhA-resistant group.Conclusions Although TTNS is more effective in PhA-naive women with iOAB, it appears to be an effective therapy that can also be used in the management of PhA-resistant women with iOAB.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 28 条
  • [21] Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women
    Schreiner, Lucas
    dos Santos, Thais Guimaraes
    Knorst, Mara Regina
    da Silva Filho, Irenio Gomes
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2010, 21 (09) : 1065 - 1070
  • [22] Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial
    Sonmez, Rafet
    Yildiz, Necmettin
    Alkan, Hakan
    [J]. ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2022, 65 (01)
  • [23] Tarcan T, 2012, UROLOGY B, V21, P113
  • [24] Efficacy of Electrical Pudendal Nerve Stimulation versus Transvaginal Electrical Stimulation in Treating Female Idiopathic Urgency Urinary Incontinence
    Wang, Siyou
    Lv, Jianwei
    Feng, Xiaoming
    Lv, Tingting
    [J]. JOURNAL OF UROLOGY, 2017, 197 (06) : 1496 - 1501
  • [25] Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity
    Yamanishi, T
    Yasuda, K
    Sakakibara, R
    Hattori, T
    Suda, S
    [J]. UROLOGY, 2000, 55 (03) : 353 - 357
  • [26] Comparison of the efficacy of intravaginal electrical stimulation in women with idiopathic overactive bladder naive and refractory to pharmacological agents
    Yildiz, Necmettin
    Unal, Burak
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2023, 34 (09) : 2099 - 2105
  • [27] Yildiz N, 2022, INT BRAZ J UROL, V48, P662, DOI [10.1590/s1677-5538.ibju.2021.0837, 10.1590/S1677-5538.IBJU.2021.0837]
  • [28] Yildiz N, 2021, INT BRAZ J UROL, V47, P1150, DOI [10.1590/s1677-5538.ibju.2021.0161, 10.1590/S1677-5538.IBJU.2021.0161]